Shanghai FDA Withdraws GMP Certificates, Suspends Production Of Drug Makers As Part Of “Five Links” Program
• By PharmAsia News
SHANGAHI - Shanghai FDA withdrew two GMP certificates and suspended the production of two companies in an effort to enhance compliance by drug and device manufacturers to the "five links" program, the Shanghai government announced Dec. 10
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
